TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
AstraZeneca AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
16,354,993
|
14,848,809
|
11,153,233 |
Financial expenses |
48,937
|
136,858
|
45,566 |
Earnings before taxes |
7,458,093
|
-1,856,708
|
2,251,024 |
EBITDA |
3,760,004
|
2,655,482
|
2,514,643 |
Total assets |
32,917,808
|
24,268,127
|
30,905,260 |
Current assets |
3,354,001
|
3,033,617
|
3,124,603 |
Current liabilities |
2,187,545
|
2,242,121
|
1,980,952 |
Equity capital |
27,987,626
|
19,006,335
|
25,573,898 |
- share capital |
185,112
|
184,574
|
200,843 |
Employees (average) |
7,248
|
6,875
|
6,814 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
85.0%
|
78.3%
|
82.7% |
Turnover per employee |
2,256
|
2,160
|
1,637 |
Profit as a percentage of turnover |
45.6%
|
-12.5%
|
20.2% |
Return on assets (ROA) |
22.8%
|
-7.1%
|
7.4% |
Current ratio |
153.3%
|
135.3%
|
157.7% |
Return on equity (ROE) |
26.6%
|
-9.8%
|
8.8% |
Change turnover |
1,462,960
|
4,598,995
|
663,251 |
Change turnover % |
10%
|
45%
|
6% |
Chg. No. of employees |
373
|
61
|
181 |
Chg. No. of employees % |
5%
|
1%
|
3% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.